Laura Benjamin
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Laura E.
Benjamin was the founder of Oncxerna Therapeutics, Inc., founded in 2018, where the titles held included President, Chief Executive Officer & Director from 2018 to 2023.
The current jobs include Independent Director at Allarity Therapeutics A and Independent Director at Allarity Therapeutics, Inc. starting in 2023.
The education history includes a doctorate from the University of Pennsylvania and an undergraduate degree from Barnard College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.01.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2023 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Gründer | 01.08.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barnard College
Barnard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Develops cancer medications | Health Technology |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen